Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy - Lei, Jieping; Rudolph, Anja; Moysich, Kirsten B. (Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015)
Aus: Breast Cancer Research 17 (2015). <http://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-015-0522-2>